NowRx Partners with Parata Systems to Streamline Pharmacist Verification, Increase Accuracy

NowRx, the same-day, free-delivery pharmacy, and Parata Systems, a leader in automated dispensing with high speed and accuracy, today announced a technology partnership to create an industry-first process that significantly streamlines pharmacist verification and fill speeds.

Through a unique combination of Parata’s Max®, a vial-filling robot with image capture, and NowRx’s automated image analytics software, NowRx believes it can improve prescription verification efficiency by more than 25% compared to the manual processes typically found in traditional pharmacies. In addition to increased efficiency, this technology dramatically reduces verification errors.

Researchers at the University of Arizona found that traditional community pharmacies average a prescription dispensing error rate between 1.4% and 1.8%(1), equating to more than 80 million prescription dispensing errors on the nearly 6 billion annual prescriptions dispensed throughout the U.S.(2) NowRx’s technology significantly reduces these dispensing errors which are common in traditional pharmacies who use older technology or manual processes.

“NowRx is leading the charge in reinventing the pharmacy space from the ground up and we are pleased that our technology is helping advance their mission of increasing pharmacy efficiency and safety,” said Mark Longley, EVP of Sales and Marketing at Parata.

By integrating Parata Max into its custom Pharmacy Management System, QuickFill, NowRx is able to utilize Parata Max’s image capture before capping to automatically run an imprint analysis. This enables NowRx’s pharmacists to more rapidly verify prescriptions. This technology partnership further fuels NowRx’s disruption of the $330bn pharmacy space and the goal it shares with Parata of improving patient prescription adherence, increasing healthcare efficiency and, ultimately, bettering the health of its customers.

“A critical component of NowRx’s vision for modernizing pharmacy is a better fulfillment process than counting trays and counting in fives – a system that has remained practically unchanged for 50 years. We knew automation was the key to re-engineering pharmacy and Parata Max offered us the most innovative solution on which to build,” said Cary Breese, CEO of NowRx. “Automations like these are the only way to be successful in a same-day delivery pharmacy offering, while raising the bar for patient safety. This is just the beginning of a number of innovations that we are developing to further revolutionize the pharmacy space.”

About Parata Systems

Parata Systems provides pharmacy technology solutions to reduce costs, improve health outcomes, and enhance the patient experience by offering the most comprehensive pharmacy automation portfolio with medication adherence packaging, high-speed robotic dispensing technologies, and pharmacy workflow solutions. Discover how pharmacies across all practice settings use our solutions to stay out in front at parata.com.

About NowRx

NowRx is an on-demand pharmacy founded with the goal of developing software, artificial intelligence, robotics, and logistics to create the most convenient retail pharmacy service available. NowRx focuses on free same-day delivery for prescription and OTC medications, eliminating the need to visit a pharmacy. NowRx hand-delivers all available prescription medications door-to-door, on the same day, through its fleet of friendly, trained drivers. Using NowRx’s proprietary pharma-efficiency technology, NowRx’s team of pharmacists fill prescriptions at its locally-based, state-of-the-art, and fully-licensed pharmacies. With NowRx, consumers can reach their pharmacist on the second ring or instantly through video chat and will never, ever waste time in pharmacy waiting lines again. NowRx recently launched its third crowd-funding round on SeedInvest. Learn more at http://www.nowrx.com. Click here for a video about NowRx.

This Company’s profile and accompanying offering materials may contain forward-looking statements and information relating to, among other things, the Company, its business plan and strategy, and its industry. These statements reflect management’s current views with respect to future events based on information currently available and are subject to risks and uncertainties that could cause the Company’s actual results to differ materially. Investors are cautioned not to place undue reliance on these forward-looking statements as they are meant for illustrative purposes and they do not represent guarantees of future results, levels of activity, performance, or achievements, all of which cannot be made. The company does not undertake any obligation to revise or update these forward-looking statements to reflect events or circumstances after such date or to reflect the occurrence of unanticipated events.

You can read the original press release here.

 

NowRx Media Contacts:
Angela Jacobson, 714.454.8776 / angela@mwebbcom.com, mWEBB Communications
Melanie Webber, 949.307.1723 / melanie@mwebbcom.com, mWEBB Communications

(1) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173242/

(2) https://www.iqvia.com/insights/the-iqvia-institute/reports/medicine-use-and-spending-in-the-us-a-review-of-2018-and-outlook-to-2023